INVESTVIEW, INC. ANNOUNCES SETTLEMENT OF OUTSTANDING SEC INQUIRY
January 21, 2025 08:00 ET
|
Investview, Inc.
HAVERFORD, PA, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Investview, Inc. (OTCQB: INVU), operates a diversified financial technology services company offering multiple business units across key sectors....
Carmell Announces Closing of Elevai Skincare Acquisition
January 16, 2025 08:00 ET
|
Carmell Corporation
Carmell Announces Closing of Elevai Skincare Acquisition
GLP-1 Medications Fuel Growth in Medical Aesthetics, with Weight Loss Accounting for 11% of Non-Surgical Spending in 2024
January 09, 2025 09:00 ET
|
Guidepoint Qsight
GLP-1 medications drove 13% of non-surgical aesthetic spend in 2024, reshaping the $19.2B industry as medspas see rising revenue and younger patients.
Cytrellis Biosystems launches Updated Next-Generation Skin Removal Treatment ellacor® 2.0, fueled by new leadership and financing
January 07, 2025 08:15 ET
|
Cytrellis Bioscience
Cytrellis marks new era of growth with the launch of ellacor 2.0, fueled by the completion of new financing and theappointment of Dr. Denise Dajles as CEO.
Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out
January 03, 2025 08:00 ET
|
Carmell Corporation
PITTSBURGH, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, “we”, “our”, or “us”), today...
Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
January 02, 2025 08:00 ET
|
Carmell Corporation
Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products
Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
December 24, 2024 08:30 ET
|
Carmell Corporation
Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out
Trent Renta Promoted to Chief Operating Officer at Olansky Dermatology & Aesthetics in Atlanta, Georgia
November 18, 2024 16:44 ET
|
Olansky Dermatology & Aesthetics
Trent Renta promoted to Chief Operating Officer
at Olansky Dermatology & Aesthetics in Atlanta, Georgia.
Olansky Dermatology & Aesthetics co-founder Dr. David Olansky retires after more than 40 years of clinical practice
October 10, 2024 12:24 ET
|
Olansky Dermatology & Aesthetics
Olansky Dermatology & Aesthetics co-founder Dr. David Olansky
retires after more than 40 years of clinical practice.
LeaderMed Group and Combiphar Form Joint Venture on LM-008, a Novel GLP-1 Dual Agonist, Targeting Indonesia's High Diabetes and/or Obesity Prevalence
September 30, 2024 22:00 ET
|
LeaderMed Group; Combiphar
LeaderMed and Combiphar form a joint venture to tackle Indonesia’s diabetes and obesity crisis with LM-008 and UltraSculpt, launching a Phase 3 trial.